黄艳娟

黄艳娟

副教授

研究领域：水凝胶递药系统的开发及其在临床重大疾病中的预防与治疗应用。

联系邮箱： huangyj256@mail.sysu.edu.cn

个人简介

黄艳娟，中山大学药学院，副教授，硕导。2020年毕业于中山大学药学院，获药剂学博士学位。担任ACS Appl. Mater. Interfaces、Int. J. Pharmaceut.、Acta Biomater.、Acs omega、Int J Biol Macromol等期刊审稿人。Chinese chemical letters、View杂志青年编委，pharmaceutics 杂志特刊主题"ROS-Mediated Nano Drug Delivery for Antitumor Therapy"客座编辑（欢迎投稿，截稿日期2026.08).

研究方向

水凝胶递药系统的开发及其在临床重大疾病中的预防与治疗应用。

主持科研项目

（1）国家自然科学基金青年基金，2022.01至2024.12，30万，主持；

（2）广东省自然科学基金-青年提升,2024.01-2026.12，30万，主持，

（3）广州市基础与应用基础研究-青年博士“启航”项目，2024.01-2025.12，5万，主持；

代表性成果

  1. X. Shi, Z. Lin, D. Xiao, W. Li, J. Wang, Y. He, C. Wang, G. Ye, Y. Liu, Y. Huang*, C. Zhao*. Pathology-responsive light-triggered conjunctival adhesive implantable hydrogels for effective anti-scarring after glaucoma filtering surgery, Journal of Controlled Release, 392, (2026), 114677.
  2. Z. Lin#, Z. Liu#, Y. Huang*, C. Zhao*, Postoperative abdominal adhesions: pathogenesis and advances in hydrogel-based multimodal prevention strategies, Acta Biomaterialia 204 (2025) 76-108.
  3. T. Zhang#, X. Shi#, Y. Huang*, Y. Gong, Y. He, D. Xiao, S. Wang, C. Zhao*. Oxidized fucoidan-based nanocomposite hydrogel for cryptotanshinone delivery and prevention of postoperative abdominal adhesions, Journal of Controlled Release, 382 (2025) 113733. （中科院1区Top）
  4. Y. Huang#, M. Xia#, C. Xu, Z. Lin, M. Chen, X. Shi, Y. Ding, Y. Xiao, C. Zhao*, A GSH-responsive oxidative stress nanoamplifier for self-augmented chemo/chemodynamic therapy to reverse cisplatin resistance, Acta Biomaterialia, 193, (2025) 440-454.（中科院1区Top）
  5. Y. Huang#, X. Dai#, Y. Gong#, L. Ren, Y. Luo, Y. Sun, M. Chen, J. Jiang, Z. Guan, C. Zhao*, ROS-responsive sprayable hydrogel as ROS scavenger and GATA6+ macrophages trap for the prevention of postoperative abdominal adhesions, Journal of Controlled Release, 369 (2024) 573-590. （中科院1区Top）
  6. L. Ren#, Y. Luo#, Y. Huang*, X. Shi, H. Lin, T. Zhang, Y. Gong, Y. Liu, D. Zheng, W. Li, D. Xiao, S. Wang, C. Zhao*. Engineering ROS-responsive double network hydrogel as bioactive barrier for postoperative abdominal adhesions prevention, Bioactive Materials 53 (2025) 269-286.
  7. J. Jiang#, Y. Huang#, Z. Zeng and C. Zhao*. Harnessing Engineered Immune Cells and Bacteria as Drug Carriers for Cancer Immunotherapy, ACS Nano, 17, (2023), 843–884.（中科院1区Top）
  8. J. Chen#, X. Tan#, Y. Huang#, *(共一第三，共通讯), C. Xu, Z. Zeng, T. Shan, Z. Guan, X. Xu, Z. Huang, C. Zhao*. Reactive oxygen species-activated self-amplifying prodrug nanoagent for tumor-specific Cu-chelate chemotherapy and cascaded photodynamic therapy, Biomaterials, 284, (2022) 121513.（中科院1区Top）
  9. Y. Huang#, X. Dai#, Z. Guan#, D. Liu, L. Ren, M. Chen, Z. Zeng, J. Jiang, Y. Luo, Y. He, M. Huang, C. Zhao*. A DNA damage nanoamplifier for the chemotherapy of triple-negative breast cancer via DNA damage induction and repair blocking, International journal of pharmaceutics, 622,(2022), 121897（药学2区Top）
  10. 黄艳娟，赵春顺，关梓琳。一种近红外光激活型巨噬细胞-纳米前药靶向递药系统的构建及其应用，专利号：202110760793.7，发明授权